Trade Walgreen Boots Alliance - WBA CFD
Add to favourite- Summary
- Historical Data
- Events
- Income Statement
- Balance Sheet
- Cash Flow
- Ownership
| Spread | 0.05 | ||||||||
|
Long position overnight fee
Long position overnight fee
Go to platform | -0.024068% | ||||||||
|
Short position overnight fee
Short position overnight fee
Go to platform | 0.001846% | ||||||||
| Overnight fee time | 21:00 (UTC) | ||||||||
| Min traded quantity | 1 | ||||||||
| Currency | USD | ||||||||
| Margin | 20% | ||||||||
| Stock exchange | United States of America | ||||||||
| Commission on trade | 0% |
*Information provided by Capital.com
Walgreens Boots Alliance Inc ESG Risk Ratings
‘B’ score indicates good relative ESG performance and above average degree of transparency in reporting material ESG data publicly.
| Prev. Close* | 33.77 |
| Open* | 33.82 |
| 1-Year Change* | -28.27% |
| Day's Range* | 33.74 - 34.14 |
| 52 wk Range | 30.39-48.48 |
| Average Volume (10 days) | 9.05M |
| Average Volume (3 months) | 143.44M |
| Market Cap | 29.17B |
| P/E Ratio | -100.00K |
| Shares Outstanding | 862.50M |
| Revenue | 133.29B |
| EPS | -3.64 |
| Dividend (Yield %) | 5.67711 |
| Beta | 0.72 |
| Next Earnings Date | Jun 28, 2023 |
All data is provided by Refinitiv, except for data marked with an asterisk, which is *data provided by Capital.com
- Last Week
- Last Month
- Last Year
- Last two Years
- Max
- Daily
- Weekly
- Monthly
| Date | Close | Change | Change (%) | Open | High | Low |
|---|---|---|---|---|---|---|
| Mar 29, 2023 | 34.13 | 0.20 | 0.59% | 33.93 | 34.18 | 33.64 |
| Mar 28, 2023 | 33.77 | 0.46 | 1.38% | 33.31 | 34.37 | 32.95 |
| Mar 27, 2023 | 32.91 | -0.02 | -0.06% | 32.93 | 33.24 | 32.73 |
| Mar 24, 2023 | 32.67 | 0.39 | 1.21% | 32.28 | 32.76 | 31.84 |
| Mar 23, 2023 | 32.29 | -0.03 | -0.09% | 32.32 | 32.74 | 31.98 |
| Mar 22, 2023 | 32.46 | -0.86 | -2.58% | 33.32 | 33.67 | 32.44 |
| Mar 21, 2023 | 33.53 | 0.27 | 0.81% | 33.26 | 33.80 | 33.17 |
| Mar 20, 2023 | 33.16 | 0.39 | 1.19% | 32.77 | 33.38 | 32.77 |
| Mar 17, 2023 | 32.91 | -0.20 | -0.60% | 33.11 | 33.31 | 32.51 |
| Mar 16, 2023 | 33.36 | 0.36 | 1.09% | 33.00 | 33.60 | 32.86 |
| Mar 15, 2023 | 33.52 | 0.72 | 2.20% | 32.80 | 33.68 | 32.58 |
| Mar 14, 2023 | 33.27 | -0.44 | -1.31% | 33.71 | 33.83 | 32.79 |
| Mar 13, 2023 | 33.53 | 0.59 | 1.79% | 32.94 | 33.70 | 32.92 |
| Mar 10, 2023 | 33.23 | -0.05 | -0.15% | 33.28 | 33.61 | 32.87 |
| Mar 9, 2023 | 33.28 | -0.98 | -2.86% | 34.26 | 34.50 | 33.24 |
| Mar 8, 2023 | 34.46 | 0.32 | 0.94% | 34.14 | 34.51 | 33.99 |
| Mar 7, 2023 | 34.10 | -1.30 | -3.67% | 35.40 | 35.49 | 34.08 |
| Mar 6, 2023 | 35.41 | -0.50 | -1.39% | 35.91 | 36.12 | 35.32 |
| Mar 3, 2023 | 36.05 | 0.52 | 1.46% | 35.53 | 36.18 | 35.29 |
| Mar 2, 2023 | 35.37 | 0.26 | 0.74% | 35.11 | 35.37 | 34.83 |
Walgreen Boots Alliance Events
| Time (UTC) | Country | Event |
|---|---|---|
| No events scheduled | ||
- Annual
- Quarterly
| 2022 | 2021 | 2020 | 2019 | 2018 | |
|---|---|---|---|---|---|
| Total revenue | 132703 | 132509 | 121982 | 120074 | 131537 |
| Revenue | 132703 | 132509 | 121982 | 120074 | 131537 |
| Cost of Revenue, Total | 104437 | 104442 | 95905 | 91915 | 100745 |
| Gross Profit | 28266 | 28067 | 26077 | 28159 | 30792 |
| Total Operating Expense | 130981 | 130291 | 121070 | 115308 | 125426 |
| Selling/General/Admin. Expenses, Total | 24175 | 23636 | 21749 | 22048 | 23465 |
| Depreciation / Amortization | |||||
| Interest Expense (Income) - Net Operating | -451 | 1156 | -302 | -164 | -208 |
| Unusual Expense (Income) | 2818 | 1057 | 3718 | 1509 | 1424 |
| Operating Income | 1722 | 2218 | 912 | 4766 | 6111 |
| Interest Income (Expense), Net Non-Operating | 2173 | -499 | -602 | -495 | -595 |
| Net Income Before Taxes | 3985 | 1995 | 446 | 4359 | 5975 |
| Net Income After Taxes | 4015 | 1328 | 107 | 3782 | 4852 |
| Minority Interest | 271 | 39 | 42 | 26 | -7 |
| Equity In Affiliates | 50 | 627 | 31 | 8 | 54 |
| Net Income Before Extra. Items | 4336 | 1994 | 180 | 3816 | 4899 |
| Net Income | 4336 | 2542 | 457 | 3982 | 5024 |
| Income Available to Common Excl. Extra. Items | 4337 | 1994 | 179 | 3816 | 4899 |
| Income Available to Common Incl. Extra. Items | 4337 | 2542 | 456 | 3982 | 5024 |
| Diluted Net Income | 4337 | 2542 | 456 | 3982 | 5024 |
| Diluted Weighted Average Shares | 865.9 | 866.4 | 880.3 | 923.5 | 995 |
| Diluted EPS Excluding Extraordinary Items | 5.00866 | 2.30148 | 0.20334 | 4.13211 | 4.92362 |
| Dividends per Share - Common Stock Primary Issue | 1.91 | 1.87 | 1.83 | 1.76 | 1.6 |
| Diluted Normalized EPS | 7.12403 | 3.11358 | 3.0188 | 5.54981 | 5.72016 |
| Other, Net | 90 | 276 | 136 | 88 | 459 |
| Total Extraordinary Items | 0 | 548 | 277 | 166 | 125 |
| Other Operating Expenses, Total | 2 | 0 | |||
| Total Adjustments to Net Income | 1 | -1 |
| Aug 2022 | May 2022 | Feb 2022 | Nov 2021 | Aug 2021 | |
|---|---|---|---|---|---|
| Total revenue | 32449 | 32597 | 33756 | 33901 | 34262 |
| Revenue | 32449 | 32597 | 33756 | 33901 | 34262 |
| Cost of Revenue, Total | 26038 | 26025 | 26047 | 26326 | 26758 |
| Gross Profit | 6411 | 6572 | 7709 | 7575 | 7504 |
| Total Operating Expense | 33125 | 32500 | 32738 | 32618 | 33347 |
| Selling/General/Admin. Expenses, Total | 6339 | 6235 | 6599 | 6204 | 6300 |
| Depreciation / Amortization | 160 | ||||
| Interest Expense (Income) - Net Operating | -88 | -127 | -103 | -100 | 55 |
| Unusual Expense (Income) | 835 | 367 | 194 | 187 | 73 |
| Operating Income | -676 | 97 | 1018 | 1283 | 915 |
| Interest Income (Expense), Net Non-Operating | -111 | -104 | -100 | 2489 | -95 |
| Other, Net | 29 | -11 | 29 | 42 | 87 |
| Net Income Before Taxes | -758 | -18 | 947 | 3814 | 907 |
| Net Income After Taxes | -523 | 224 | 775 | 3539 | 321 |
| Minority Interest | 85 | 60 | 78 | 48 | 14 |
| Equity In Affiliates | 21 | 5 | 31 | -7 | 23 |
| Net Income Before Extra. Items | -417 | 289 | 884 | 3580 | 358 |
| Total Extraordinary Items | 0 | 0 | 0 | 0 | 268 |
| Net Income | -417 | 289 | 884 | 3580 | 626 |
| Total Adjustments to Net Income | 2 | -1 | 0 | 1 | |
| Income Available to Common Excl. Extra. Items | -415 | 289 | 883 | 3580 | 359 |
| Income Available to Common Incl. Extra. Items | -415 | 289 | 883 | 3580 | 627 |
| Diluted Net Income | -415 | 289 | 883 | 3580 | 627 |
| Diluted Weighted Average Shares | 864.5 | 865.3 | 865.2 | 867.6 | 867 |
| Diluted EPS Excluding Extraordinary Items | -0.48005 | 0.33399 | 1.02057 | 4.12633 | 0.41407 |
| Dividends per Share - Common Stock Primary Issue | 0.4775 | 0.4775 | 0.4775 | 0.4775 | 0.4675 |
| Diluted Normalized EPS | 0.14777 | 0.60967 | 1.20407 | 4.32632 | 0.4688 |
| Other Operating Expenses, Total | 1 | 1 | 1 | 1 |
- Annual
- Quarterly
| 2021 | 2020 | 2019 | 2018 | 2017 | |
|---|---|---|---|---|---|
| Total Current Assets | 15814 | 18073 | 18700 | 17846 | 19753 |
| Cash and Short Term Investments | 1193 | 516 | 1023 | 785 | 3301 |
| Cash & Equivalents | 1193 | 516 | 1023 | 785 | 3301 |
| Total Receivables, Net | 5663 | 7132 | 7226 | 6573 | 6528 |
| Accounts Receivable - Trade, Net | 5663 | 7132 | 7226 | 6573 | 6528 |
| Total Inventory | 8159 | 9451 | 9333 | 9565 | 8899 |
| Other Current Assets, Total | 799 | 974 | 1118 | 923 | 1025 |
| Total Assets | 81285 | 87174 | 67598 | 68124 | 66009 |
| Property/Plant/Equipment, Total - Net | 34140 | 35066 | 13478 | 13911 | 13642 |
| Property/Plant/Equipment, Total - Gross | 47214 | 47521 | 24789 | 24424 | 22960 |
| Accumulated Depreciation, Total | -13073 | -12456 | -11310 | -10513 | -9318 |
| Goodwill, Net | 12421 | 15268 | 16560 | 16914 | 15632 |
| Intangibles, Net | 9936 | 10753 | 10876 | 11783 | 10156 |
| Long Term Investments | 6987 | 7338 | 6851 | 6610 | 6320 |
| Other Long Term Assets, Total | 1987 | 676 | 1133 | 1060 | 506 |
| Total Current Liabilities | 22054 | 27070 | 25769 | 21667 | 18547 |
| Accounts Payable | 11136 | 14458 | 14341 | 13566 | 12494 |
| Accrued Expenses | 9482 | 8931 | 5468 | 5857 | 1228 |
| Notes Payable/Short Term Debt | 0 | 1517 | 2400 | 430 | 0 |
| Current Port. of LT Debt/Capital Leases | 1342 | 2055 | 3338 | 1536 | 251 |
| Other Current Liabilities, Total | 94 | 109 | 222 | 278 | 4574 |
| Total Liabilities | 57866 | 66536 | 44087 | 42117 | 38543 |
| Total Long Term Debt | 8649 | 13223 | 11098 | 12431 | 12684 |
| Long Term Debt | 7675 | 12203 | 11098 | 12431 | 12684 |
| Deferred Income Tax | 1850 | 1498 | 1785 | 1815 | 2281 |
| Minority Interest | 721 | 498 | 641 | 682 | 808 |
| Other Liabilities, Total | 24592 | 24247 | 4794 | 5522 | 4223 |
| Total Equity | 23419 | 20638 | 23511 | 26007 | 27466 |
| Common Stock | 12 | 12 | 12 | 12 | 12 |
| Additional Paid-In Capital | 10988 | 10761 | 10639 | 10493 | 10339 |
| Retained Earnings (Accumulated Deficit) | 35121 | 34210 | 35815 | 33551 | 30137 |
| Treasury Stock - Common | -20593 | -20575 | -19057 | -15047 | -9971 |
| Other Equity, Total | -2080 | -3760 | -3901 | -3005 | -3051 |
| Total Liabilities & Shareholders’ Equity | 81285 | 87174 | 67598 | 68124 | 66009 |
| Total Common Shares Outstanding | 865.374 | 865.604 | 895.388 | 952.133 | 1023.85 |
| Unrealized Gain (Loss) | -29 | -10 | 3 | 3 | |
| Capital Lease Obligations | 974 | 1020 |
| May 2022 | Feb 2022 | Nov 2021 | Aug 2021 | May 2021 | |
|---|---|---|---|---|---|
| Total Current Assets | 18872 | 16824 | 20314 | 15814 | 26607 |
| Cash and Short Term Investments | 4458 | 1887 | 4135 | 1193 | 1345 |
| Cash & Equivalents | 2285 | 1887 | 4135 | 1193 | 1345 |
| Total Receivables, Net | 5034 | 5328 | 5960 | 5663 | 5153 |
| Accounts Receivable - Trade, Net | 5034 | 5328 | 5960 | 5663 | 5153 |
| Total Inventory | 8520 | 8947 | 9475 | 8159 | 8333 |
| Other Current Assets, Total | 860 | 662 | 744 | 799 | 11776 |
| Total Assets | 92759 | 92683 | 96507 | 81285 | 91920 |
| Property/Plant/Equipment, Total - Net | 33158 | 33937 | 34121 | 34140 | 34324 |
| Goodwill, Net | 21901 | 21958 | 21520 | 12421 | 12493 |
| Intangibles, Net | 11583 | 12352 | 12770 | 9936 | 10435 |
| Long Term Investments | 5777 | 6247 | 6367 | 6987 | 6778 |
| Other Long Term Assets, Total | 1468 | 1365 | 1415 | 1987 | 1283 |
| Total Current Liabilities | 24067 | 22699 | 24447 | 22054 | 34475 |
| Accounts Payable | 11794 | 11178 | 12452 | 11136 | 11290 |
| Accrued Expenses | 9389 | 9245 | 9202 | 9482 | 8922 |
| Notes Payable/Short Term Debt | 1200 | 1264 | 875 | 0 | 2390 |
| Current Port. of LT Debt/Capital Leases | 1624 | 879 | 1809 | 1342 | 5610 |
| Other Current Liabilities, Total | 60 | 133 | 109 | 94 | 6263 |
| Total Liabilities | 66506 | 65982 | 70244 | 57866 | 69819 |
| Total Long Term Debt | 11589 | 12168 | 12162 | 8649 | 8721 |
| Long Term Debt | 10670 | 11203 | 11199 | 7675 | 7732 |
| Capital Lease Obligations | 919 | 965 | 963 | 974 | 989 |
| Deferred Income Tax | 1578 | 1892 | 1970 | 1850 | 1309 |
| Minority Interest | 4904 | 4978 | 7103 | 721 | 805 |
| Other Liabilities, Total | 24368 | 24245 | 24562 | 24592 | 24509 |
| Total Equity | 26253 | 26701 | 26263 | 23419 | 22101 |
| Common Stock | 12 | 12 | 12 | 12 | 12 |
| Additional Paid-In Capital | 11029 | 10973 | 10966 | 10988 | 10971 |
| Retained Earnings (Accumulated Deficit) | 38632 | 38757 | 38286 | 35121 | 34908 |
| Treasury Stock - Common | -20696 | -20712 | -20700 | -20593 | -20610 |
| Unrealized Gain (Loss) | -171 | -154 | -74 | -29 | 11 |
| Other Equity, Total | -2553 | -2175 | -2227 | -2080 | -3191 |
| Total Liabilities & Shareholders’ Equity | 92759 | 92683 | 96507 | 81285 | 91920 |
| Total Common Shares Outstanding | 864.257 | 863.773 | 863.842 | 865.374 | 864.882 |
| Short Term Investments | 2173 |
- Annual
- Quarterly
| 2021 | 2020 | 2019 | 2018 | 2017 | |
|---|---|---|---|---|---|
| Net income/Starting Line | 2512 | 424 | 3962 | 5031 | 4101 |
| Cash From Operating Activities | 5555 | 5485 | 5595 | 8263 | 7255 |
| Cash From Operating Activities | 1973 | 1927 | 2038 | 1770 | 1654 |
| Deferred Taxes | 233 | -43 | 100 | -322 | -434 |
| Non-Cash Items | 409 | 2235 | 234 | -154 | 312 |
| Cash Taxes Paid | 336 | 600 | 900 | 600 | 1100 |
| Cash Interest Paid | 916 | 584 | 676 | 577 | 643 |
| Changes in Working Capital | 428 | 942 | -739 | 1938 | 1622 |
| Cash From Investing Activities | 4072 | -1297 | -2307 | -5501 | -843 |
| Capital Expenditures | -1379 | -1374 | -1702 | -1367 | -1351 |
| Other Investing Cash Flow Items, Total | 5451 | 77 | -605 | -4134 | 508 |
| Cash From Financing Activities | -9036 | -4647 | -3047 | -5295 | -12934 |
| Financing Cash Flow Items | -241 | -158 | 74 | -98 | -45 |
| Total Cash Dividends Paid | -1617 | -1747 | -1643 | -1739 | -1723 |
| Issuance (Retirement) of Stock, Net | -51 | -1534 | -3986 | -5054 | -5003 |
| Issuance (Retirement) of Debt, Net | -7127 | -1208 | 2508 | 1596 | -6163 |
| Foreign Exchange Effects | -66 | -1 | -9 | 11 | 26 |
| Net Change in Cash | 525 | -460 | 232 | -2522 | -6496 |
| May 2022 | Feb 2022 | Nov 2021 | Aug 2021 | May 2021 | |
|---|---|---|---|---|---|
| Net income/Starting Line | 4566 | 4337 | 3531 | 2512 | 1899 |
| Cash From Operating Activities | 3812 | 2184 | 1099 | 5555 | 4310 |
| Cash From Operating Activities | 1502 | 1024 | 500 | 1973 | 1455 |
| Deferred Taxes | -168 | 94 | 164 | 233 | -210 |
| Non-Cash Items | -3052 | -2502 | -2539 | 409 | 685 |
| Cash Taxes Paid | 291 | 201 | 34 | 336 | 305 |
| Cash Interest Paid | 336 | 211 | 153 | 916 | 889 |
| Changes in Working Capital | 964 | -769 | -557 | 428 | 481 |
| Cash From Investing Activities | -1262 | -2181 | -1958 | 4072 | -1341 |
| Capital Expenditures | -1241 | -870 | -454 | -1379 | -1001 |
| Other Investing Cash Flow Items, Total | -21 | -1311 | -1504 | 5451 | -340 |
| Cash From Financing Activities | 753 | 769 | 3877 | -9036 | -1856 |
| Financing Cash Flow Items | -1948 | -2129 | -8 | -241 | -114 |
| Total Cash Dividends Paid | -1251 | -833 | -413 | -1617 | -1212 |
| Issuance (Retirement) of Stock, Net | -174 | -155 | -135 | -51 | -69 |
| Issuance (Retirement) of Debt, Net | 4126 | 3886 | 4433 | -7127 | -461 |
| Foreign Exchange Effects | -33 | -16 | -20 | -66 | -55 |
| Net Change in Cash | 3270 | 756 | 2998 | 525 | 1058 |
| Investor Name | Investor Type | Percent Outstanding | Shares Held | Shares change | Holdings Date | Turnover Rating |
|---|---|---|---|---|---|---|
| Alliance Sante Participations S.A. | Corporation | 16.787 | 144788821 | 0 | 2022-11-28 | LOW |
| The Vanguard Group, Inc. | Investment Advisor/Hedge Fund | 7.0884 | 61137298 | -1082903 | 2022-12-31 | LOW |
| State Street Global Advisors (US) | Investment Advisor/Hedge Fund | 6.6586 | 57430654 | 4056466 | 2022-12-31 | LOW |
| BlackRock Institutional Trust Company, N.A. | Investment Advisor | 4.6839 | 40398437 | 1118368 | 2022-12-31 | LOW |
| Capital World Investors | Investment Advisor | 2.4218 | 20887809 | 2726658 | 2022-12-31 | LOW |
| Geode Capital Management, L.L.C. | Investment Advisor/Hedge Fund | 1.5538 | 13401774 | 98144 | 2022-12-31 | LOW |
| Fidelity Management & Research Company LLC | Investment Advisor | 1.5197 | 13107524 | 267171 | 2022-12-31 | LOW |
| Invesco Capital Management LLC | Investment Advisor | 1.3284 | 11457230 | 1182354 | 2022-12-31 | LOW |
| Invesco Capital Management (QQQ Trust) | Investment Advisor | 1.3049 | 11254469 | 58133 | 2023-02-28 | LOW |
| Wells Fargo Advisors | Research Firm | 0.9587 | 8268730 | -91102 | 2022-12-31 | LOW |
| Legal & General Investment Management Ltd. | Investment Advisor/Hedge Fund | 0.7235 | 6240380 | -351159 | 2022-12-31 | LOW |
| Arrowstreet Capital, Limited Partnership | Investment Advisor/Hedge Fund | 0.6949 | 5993919 | 52656 | 2022-12-31 | MED |
| BlackRock Asset Management Ireland Limited | Investment Advisor | 0.6842 | 5901561 | 158731 | 2022-12-31 | LOW |
| ProShare Advisors LLC | Investment Advisor | 0.6527 | 5629969 | 525124 | 2022-12-31 | LOW |
| Charles Schwab Investment Management, Inc. | Investment Advisor | 0.6266 | 5404696 | 120708 | 2022-12-31 | LOW |
| LSV Asset Management | Investment Advisor | 0.6233 | 5376023 | -79957 | 2022-12-31 | LOW |
| BlackRock Investment Management (UK) Ltd. | Investment Advisor/Hedge Fund | 0.6187 | 5336442 | 765477 | 2022-12-31 | LOW |
| Federated Hermes Equity Management Company of Pennsylvania | Investment Advisor | 0.6109 | 5269057 | 314410 | 2022-12-31 | LOW |
| Morgan Stanley Smith Barney LLC | Investment Advisor | 0.6102 | 5263220 | -91675 | 2022-12-31 | LOW |
| Camber Capital Management LP | Hedge Fund | 0.5797 | 5000000 | 2175000 | 2022-12-31 | MED |
Why choose Capital.com? Our numbers speak for themselves.
Capital.com Group500K+
Traders
92K+
Active clients monthly
$53M+
Monthly investing volume
$30M+
Withdrawn each month
Trading calculator
Calculate your hypothetical P&L if you had opened a CFD trade on a certain date (select a date) and closed on a different date (select a date).
- 1:1
- 20
- 100
- 500
- 1000
- 10000
Walgreen Company profile
What is Walgreen Boots Alliance?
Walgreen Boots Alliance is one of the largest pharmacy chains in the world. It is is split into three business segments: Retail Pharmacy Wholesale, Retail Pharmacy USA and Retail Pharmacy International. The company’s portfolio of retail and business brands includes Walgreens, Duane Reade, Boots and Alliance Healthcare. Among its health and beauty product brands are such household names as No7, Soap & Glory, Liz Earle and Botanics.
WBA also has one of the largest global pharmaceutical wholesale and distribution networks. The company is one of the world’s biggest purchasers of prescription drugs and many other health and wellbeing products. Walgreen Boots Alliance says its aim is to “help people across the world lead healthier and happier lives”.
Who are the key people at Walgreen Boots Alliance?
Stefano Pessina is Executive Vice Chairman and Chief Executive Officer of Walgreens Boots Alliance. The Italian-born billionaire’s career in the healthcare industry spans four decades. As Executive Deputy Chairman of Alliance UniChem, he led the company's landmark merger with Boots Group PLC in 2006. His voice carries a lot of weight in the sector.
WBA has two Co-Chief Operating Officers: Alex Gourlay and Ornella Barra. James A. Skinner serves as Executive Chairman.
What is the modern history of Walgreen Boots Alliance?
Walgreen Boots Alliance was established on December 31, 2014 after Walgreens, the US pharmacy store giant, purchased the 55% of Alliance Boots that it didn’t already own. Alliance Boots was a UK and Switzerland-based health and beauty group formed in 2006 through the merger of high street chain Boots and European pharmacy group Alliance UniChem.
What are the latest developments at Walgreen Boots Alliance?
It’s been a time of consolidation in the US healthcare industry, partly prompted by Amazon’s announcement that it is entering the sector to try to lower costs for patients. Some observers think Amazon could use its distribution expertise to undercut existing healthcare firms.
Walgreen Boots Alliance has been very active in pursuing potential deals. In September 2017, it agreed to buy 1,932 Rite Aid stores and three distribution centres for almost $4.4 billion in cash. WBA had previously sought to buy all of Rite Aid, but antitrust scrutiny scuppered the proposed deal.
In February 2018 it was reported that deal talks between Walgreens Boots Alliance and AmerisourceBergen about an acquisition of the wholesale drug distributor had ended without agreement. Walgreens already has a 26 per cent stake in Amerisource.
Since Walgreen Boots Alliance was founded at the end of 2014, the WBA share price has gone from $76 to a peak of $96 in July 2015 and back down to just $64 in October 2017. On 1 March 2018 the share price stood at $70.20, giving the company a market capitalisation of around $69.5 billion.
Our WBA chart tracks the ups and downs of the company’s share price over recent weeks and months.
Where does Walgreen Boots Alliance operate?
Walgreens Boots Alliance and the companies in which it has equity method investments have a presence in more than 25 countries around the world, with a total of over 13,000 stores. WBA also has one of the biggest global pharmaceutical wholesale and distribution networks, with over 390 distribution centres delivering to some 230,000 hospitals, health centres, pharmacies and doctors each year in over 20 countries. WBA is headquartered in Deerfield, Illinois.
Where is Walgreen Boots Alliance traded?
Walgreen is listed on the NASDAQ stock exchange. Check out Capital.com for the latest WBA chart.
| Industry: | Drug Retailers (NEC) |
108 Wilmot Rd
DEERFIELD
ILLINOIS 60015
US
Income Statement
- Annual
- Quarterly
News
Mask network price prediction: What is mask network (MASK)?
Can MASK – the native token of the Mask Network protocol – continue its recent growth?
12:42, 29 March 2023
Natural gas price forecast 2030-2050: What next for gas prices?
Where will natural gas prices head in 2023 and beyond?
17:27, 28 March 2023
Terra price prediction: What is terra (LUNA)?
What happens next to LUNA after Do Kwon's arrest?
14:22, 28 March 2023
Bitgert price prediction: Where next for BRISE?
BRISE outperformed the market in 2022, but there are some red flags
12:49, 28 March 2023
XRP price prediction: How will the court case affect the price of ripple?
As its ongoing court case looks set to conclude, what might be next for XRP?
11:13, 28 March 2023
Ripple/SEC Lawsuit: News And Update
Ripple and the US Securities and Exchange Commission are still awaiting a ruling
10:10, 28 March 2023
GBP/EUR forecast: Will the pound rise against the euro in 2023?
The British pound has been moving sideways against the Euro, yet can it regain momentum? Read on for a GBP/EUR forecast.
16:27, 24 March 2023People also watch
Still looking for a broker you can trust?
Join the 500.000+ traders worldwide that chose to trade with Capital.com